Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medicines Discovery Catapult (MDC) is the UK’s national centre for medicine research innovation. It operates as an independent not-for-profit company supporting drug discovery through advanced technologies and expertise. MDC enables biotech SMEs and innovators to progress assets from early-stage research toward clinical development by providing access to state-of-the-art labs in biomarkers, cellular sciences, translational imaging and data science. The organization focuses on de-risking new technologies and making companies “fit to fund,” catalyzing over £1bn in investment into UK life sciences since inception. It does not develop its own therapeutics but accelerates external R&D through partnerships across academia, biotech/pharma industry and government.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medicines Discovery Catapult.